Skip to Content
 

News: Lung Cancer

Team explores fungal infection quandary in lung cancer screenings

Thursday, April 25th, 2019

A recent study by Vanderbilt investigators revealed that histoplasmosis – a fungal infection that creates cancer-mimicking lesions in the lungs – is prevalent beyond previously identified regions of the United States.

Asian nations in early tobacco epidemic: study

Thursday, April 25th, 2019

Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases.

Study reframes approach to targeted therapy resistance

Thursday, April 25th, 2019

A recent study provides clinicians genomic guidance for surveillance of targeted therapy resistance in patients with EGFR-mutant non-small cell lung cancer — and more importantly — another drug option when resistance occurs.

New algorithm calculates drug synergy; initial tests involve melanoma, lung cancer

Monday, February 25th, 2019

Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren’t as effective as they could be. That could change with a new algorithm developed by a cross-disciplinary Vanderbilt University team for calculating drug synergy.

Spalluto, Lewis to lead VA lung screening initiative

Friday, January 18th, 2019

Lucy Spalluto, MD, and Jennifer Lewis, MD, MS, are co-leading the Veterans Affairs-Partnership to increase Access to Lung Screening (VA-PALS) National Program Evaluation, which aims to implement lung screening programs and improve access to early detection of lung cancer for at-risk veterans.

Lung cancer survival signal

Saturday, December 1st, 2018

A recent study shows that a cell receptor, SSTR2, is a candidate biomarker for poor prognosis and a potential therapeutic target for small cell lung cancer.

Combination therapy improves small-cell lung cancer survival

Friday, October 26th, 2018

Patients who received atezolizumab in addition to standard chemotherapy lived two months longer than those treated with chemotherapy alone, according to a recent study published in the New England Journal of Medicine.

Team’s potential lung cancer therapy lands award from SBIR

Thursday, September 27th, 2018

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.

A new target for lung cancer

Tuesday, August 21st, 2018

A recent study suggests that a transporter protein called xCT may be potential therapeutic target in lung cancer.

Lung cancer patients and advocates visit VUMC research labs

Friday, June 15th, 2018

A group of young lung cancer patients and their family members recently toured research laboratories to learn how investigators are working to find better therapies and possibly a cure for the disease.

Next Page »